TABLE 3.
Comparison of decreases in bacterial counts for TCF samples from different groups at the end of therapy, days 8 and 11
| Treatment or group | Change in mean bacterial counta (log CFU/ml) ± SD on:
|
|
|---|---|---|
| Day 8 | Day 11 | |
| Daptomycin | −2.26 ± 1.1** (n = 20) | −2.57 ± 1.2** (n = 18) |
| Rifampin | −2.48 ± 1** (n = 20) | −2.61 ± 1.1** (n = 17) |
| Linezolid | −1.06 ± 1.1* (n = 20) | −0.93 ± 0.9* (n = 18) |
| Vancomycin | −1.36 ± 1.1* (n = 20) | −1.1 ± 1* (n = 19) |
| Control group | 1.17 ± 0.6 (n = 14) | 1.06 ± 0.7 (n = 14) |
a
Changes are relative to the bacterial count at the beginning of treatment. n indicates the number of tissue cages evaluated. *, P < 0.05 for comparison to results for controls; **, P < 0.05 for comparison to results of linezolid and vancomycin treatments.